Skip to content

Clinical trials

Completed Phase 2/3 Scleroderma, Diffuse trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Scleroderma, Diffuse Phase: Phase 2/3 Status: Completed Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20131
20141
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Actelion2
Assistance Publique - Hôpitaux de Paris1
Assiut University1
Federal University of São Paulo1
Royal Brompton & Harefield NHS Foundation Trust1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Scleroderma, Diffuse6
Lung Diseases, Interstitial3
Pulmonary Fibrosis3
Scleroderma, Systemic2
Arthritis1
Connective Tissue Diseases1
Dermatomyositis1
Mixed Connective Tissue Disease1
Myositis1
Polymyositis1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.